Company: IXHL
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001213900-25-092837
Chunk: 217

Company: Incannex Healthcare Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1
Chunk 217
---
 year ended June 30, 

    2025  
    2024 
  
    Cash flows from operating activities: 

    Net loss 
     (46,885) 
     (18,459)
  
    Adjustments to reconcile net loss to net cash used in operating activities: 

    Depreciation and amortization 
     246  
     103 
  
    Stock-based compensation expense 
     2,609  
     8,928 
  
    Unrealized losses/(gains) on foreign currency remeasurement 
     294  
     28 
  
    Non-cash expense of ELOC commitment 
     1,048  
     - 
  
    Change in fair value of warrant liabilities 
     21,925  
     - 
  
    Change in fair value of convertible rights 
     (299) 
     - 
  
    Non-cash interest expense 
     302  
     - 
  
    Loss on extinguishment 
     1,472  
     - 
  
    Change in operating assets and liabilities: 

    Prepaid expenses and other current assets 
     (189) 
     369 
  
    R&D tax incentive receivable 
     5,579  
     (9,837)
  
    Trade and other payables 
     1,385  
     3,023 
  
    Net cash used in operating activities 
     (12,513) 
     (15,845)
  
    Cash flows from investing activities: 

    Purchase of property, plant and equipment 
     (8) 
     (277)
  
    Net cash used in investing activities 
     (8) 
     (277)
  
    Cash flows from financing activities: 

    Proceeds received from facility agreement 
     4,282  
     - 
  
    Repayment of facility agreement 
     (4,459) 
     - 
  
    Proceeds share issuance 
     48,343  
     - 
  
    Share issuance costs 
     (747) 
     - 
  
    Warrant issuance costs 
     (125) 
     - 
  
    Proceeds from issuance of convertible debt 
     2,779  
     - 
  
    Cancellation of warrants 
     (24,769)